Litcius/Paper detail

Differential parathyroid and kidney Ca2+-sensing receptor activation in autosomal dominant hypocalcemia 1

Wouter H. van Megen, Rebecca Tan, R. Todd Alexander, Henrik Dimke

2022EBioMedicine15 citationsDOIOpen Access PDF

Abstract

BACKGROUND: in urine). The latter promotes nephrocalcinosis and renal insufficiency. Although CaSRs throughout the body including the kidney harbor activating CASR mutations, it is not understood why only some ADH1 patients display hypercalciuria. METHODS: Activation of the CaSR was studied in mouse models and a ADH1 patient. In vitro CaSR activation was studied in HEK293 cells. FINDINGS: was normalized. In vitro experiments indicate that increased CaSR expression in the parathyroid relative to the kidney could contribute to tissue-specific CaSR activation thresholds. INTERPRETATION: balance regulation that aid in explaining the spectrum of hypercalciuria in ADH1 patients. FUNDING: Erasmus+ 2018/E+/4458087, the Canadian Institutes for Health research, the Novo Nordisk Foundation, the Beckett Foundation, the Carlsberg Foundation and Independent Research Fund Denmark.

Topics & Concepts

ReceptorMedicineKidneyCalcium-sensing receptorDifferential (mechanical device)EndocrinologyParathyroid hormoneInternal medicineBiologyCalciumPhysicsThermodynamicsParathyroid Disorders and TreatmentsKidney Stones and Urolithiasis TreatmentsThyroid and Parathyroid Surgery